Hepatitis clinical trials at University of California Health

2 in progress, 0 open to eligible people

Showing trials for

  • Tobevibart + Elebsiran in Chronic HDV Infection

    Sorry, in progress, not accepting new patients

    This is a multicenter, open label, randomized Phase 3 clinical study to evaluate the efficacy and safety of the combination of tobevibart + elebsiran for the treatment of chronic hepatitis delta in comparison to delayed treatment.

    at UCSF

  • Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)

    Sorry, not currently recruiting here

    The primary purpose of this study is to evaluate the safety and efficacy of larsucosterol, as determined by transplant-free survival through Day 90 in participants with severe alcohol-associated hepatitis (AH) with pre-treatment Maddrey Discriminant Function (MDF) score greater than or equal to (>=) 32 and Model for End-stage Liver Disease (MELD) scores 21-30, inclusive.

    at UC Davis UCLA

Last updated: